Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Paul Lespérance"'
Autor:
Jean-Philippe Miron, Maxime Couture, Véronique Desbeaumes Jodoin, Emma Bousseau, Camille Massé-Leblanc, Chantal Bolduc, Daniel M. Blumberger, Abhishek Datta, Michael A. Nitsche, Paul Lespérance
Publikováno v:
Brain Stimulation, Vol 16, Iss 5, Pp 1273-1275 (2023)
Externí odkaz:
https://doaj.org/article/05050316a14a4382bee17de3c1b0edea
Autor:
Paul Lespérance, Véronique Desbeaumes Jodoin, David Drouin, Frédéric Racicot, Jean-Philippe Miron, Christophe Longpré-Poirier, Marie-Pierre Fournier-Gosselin, Paméla Thebault, Réjean Lapointe, Nathalie Arbour, Jean-François Cailhier
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 5, p 2679 (2024)
Vagal neurostimulation (VNS) is used for the treatment of epilepsy and major medical-refractory depression. VNS has neuropsychiatric functions and systemic anti-inflammatory activity. The objective of this study is to measure the clinical efficacy an
Externí odkaz:
https://doaj.org/article/89a82a1c2ab5433c824f3ac4e99c308b
Autor:
Camille Massé-Leblanc, Véronique Desbeaumes Jodoin, Dang K. Nguyen, Paul Lespérance, Jean-Philippe Miron
Publikováno v:
Brain Stimulation, Vol 16, Iss 1, Pp 241- (2023)
Externí odkaz:
https://doaj.org/article/0af36cbd9d1e485797c7edcbec9b29d4
Autor:
Maxime Richard, Véronique Desbeaumes Jodoin, Didier Jutras-Aswad, Elie Bou Assi, Paul Lespérance, Jean-Philippe Miron
Publikováno v:
Brain Stimulation, Vol 16, Iss 1, Pp 283- (2023)
Externí odkaz:
https://doaj.org/article/366bc9b810c84b89aa79cd7fb75f3876
Autor:
Olivier Payette, Véronique Desbeaumes Jodoin, Nazim Medjahed, Camille Massé-Leblanc, Laurent Elkrief, Christophe Longpré-Poirier, Paul Lespérance, Jean-Philippe Miron
Publikováno v:
Brain Stimulation, Vol 16, Iss 1, Pp 283- (2023)
Externí odkaz:
https://doaj.org/article/18a46d23ffcf4464bd57f6a2cbfa11c4
Autor:
Maxime Couture, Nazim Medjahed, Camille Massé-Leblanc, Olivier Payette, Véronique Desbeaumes Jodoin, Paul Lespérance, Jean-Philippe Miron
Publikováno v:
Brain Stimulation, Vol 16, Iss 1, Pp 283- (2023)
Externí odkaz:
https://doaj.org/article/4ab8406529014c218e55824e05da96cc
Autor:
Clémence Noiseux, Jean-Philippe Miron, Véronique Desbeaumes Jodoin, Tian Ren Chu, Sylvain Chouinard, Paul Lespérance
Publikováno v:
NeuroSci, Vol 2, Iss 4, Pp 400-404 (2021)
Huntington’s disease (HD) is a rare genetic disorder resulting in progressive neurodegeneration leading to motor, cognitive and psychiatric symptoms. A high percentage of HD patients suffer from comorbid major depressive disorder (MDD). We are not
Externí odkaz:
https://doaj.org/article/5745f0c1987443019cccbd45b002a07a
Autor:
Laurent Elkrief, Olivier Payette, Jean-Nicolas Foucault, Christophe Longpré-Poirier, Maxime Richard, Véronique Desbeaumes Jodoin, Paul Lespérance, Jean-Philippe Miron
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
About a third of patients suffering from major depression develop treatment-resistant depression (TRD). Although repetitive transcranial magnetic stimulation (rTMS) and intravenous ketamine have proven effective for the management of TRD, many patien
Externí odkaz:
https://doaj.org/article/cc7743cc0b1747728f8d5f2129abd1db
Autor:
Christophe Longpré-Poirier, Robert-Paul Juster, Jean-Philippe Miron, Philippe Kerr, Enzo Cipriani, Véronique Desbeaumes Jodoin, Paul Lespérance
Publikováno v:
Comprehensive Psychoneuroendocrinology, Vol 10, Iss , Pp 100133- (2022)
Treatment resistant depression is challenging because patients who fail their initial treatments often do not respond to subsequent trials and their course of illness is frequently marked by chronic depression. Repetitive transcranial magnetic stimul
Externí odkaz:
https://doaj.org/article/b04d2296d62149ef87058f612508dfed
Autor:
Jean-Philippe Miron, Jack Sheen, Tony Panzarella, Molly Hyde, Farrokh Mansouri, Linsay Fox, Helena Voetterl, Véronique Desbeaumes Jodoin, Paul Lespérance, Christophe Longpré-Poirier, Robert-Paul Juster, Zafiris J. Daskalakis, Daniel M. Blumberger, Jonathan Downar
Publikováno v:
Journal of Affective Disorders Reports, Vol 6, Iss , Pp 100270- (2021)
Background: Major depressive disorder (MDD) is now the first cause of disability worldwide. So far, no validated and scalable biomarker has been identified to help with response prediction to antidepressant treatment. Cardiac biomarkers such as heart
Externí odkaz:
https://doaj.org/article/9d9a209d80e948cb9895811235782a47